Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Downgrades Ashland to Underweight, Raises Price Target to $105

JP Morgan analyst Jeffrey Zekauskas downgrades Ashland (NYSE:ASH) from Neutral to Underweight and raises the price target from $104 to $105.
byBenzinga Newsdesk
February 2, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JP Morgan analyst Jeffrey Zekauskas downgrades Ashland (NYSE:ASH) from Neutral to Underweight and raises the price target from $104 to $105.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Vistagen Announces The Two Leading Proxy Advisory Firms, Institutional Shareholder Services And Glass Lewis, Recommend Stockholders Vote “For” Proposal No. 5 To Provide Its Board With The Option To Implement A Future Reverse Stock Split, If Necessary

By Benzinga Newsdesk
October 6, 8:39 AM
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central

VTGN